North America Joint Pain Injection Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Joint Pain Injection Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Joint Pain Injection Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Joint Pain Injection Market Regional Analysis

6.2 North America Joint Pain Injection Market Revenue 2019-2028 (US$ Million)

6.3 North America Joint Pain Injection Market Forecast Analysis

7. North America Joint Pain Injection Market Analysis – by Drugs

7.1 Hyaluronic Acid

7.1.1 Overview
7.1.2 Hyaluronic Acid: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Corticosteroid

7.2.1 Overview
7.2.2 Corticosteroid: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Joint Pain Injection Market Analysis – by Joint Type

8.1 Knee

8.1.1 Overview
8.1.2 Knee: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Foot and Ankle

8.2.1 Overview
8.2.2 Foot and Ankle: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Shoulder and Elbow

8.3.1 Overview
8.3.2 Shoulder and Elbow: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Hip

8.4.1 Overview
8.4.2 Hip: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Joint Pain Injection Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Retail Pharmacies: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Hospitals Pharmacies

9.2.1 Overview
9.2.2 Hospitals Pharmacies: North America Joint Pain Injection Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Joint Pain Injection Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Joint Pain Injection Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Joint Pain Injection Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Joint Pain Injection Market Breakdown, by Drugs
10.2.1.1.2 US: North America Joint Pain Injection Market Breakdown, by Joint Type
10.2.1.1.3 US: North America Joint Pain Injection Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Joint Pain Injection Market Breakdown, by Drugs
10.2.1.2.2 Canada: North America Joint Pain Injection Market Breakdown, by Joint Type
10.2.1.2.3 Canada: North America Joint Pain Injection Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Joint Pain Injection Market Breakdown, by Drugs
10.2.1.3.2 Mexico : North America Joint Pain Injection Market Breakdown, by Joint Type
10.2.1.3.3 Mexico : North America Joint Pain Injection Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Chugai Pharmaceutical Co., Ltd.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bioventus Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Fidia Pharma USA Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Flexion Therapeutics, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Seikagaku Corporation

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Ferring B.V.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Sanofi

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Anika Therapeutics, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 OrthogenRx, Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Teva Pharmaceutical Industries Ltd.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Joint Pain Injection Market

Analysis By Drugs (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)